Synthetic Biologics Thinks Statins May Get At Root Of IBS-Constipation
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Biotech set to develop patented special-release statin formulation for a new approach to constipation-predominant irritable bowel syndrome – methane gas. The same research also underpins development of Salix’ Xifaxan for diarrhea-predominant IBS.